HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INNOGEN-B

3.635

-0.160-4.22%

Volume:5.39M

Turnover:19.67M

Market Cap:1.66B

PE:-3.95

High:3.800

Open:3.800

Low:3.605

Close:3.795

52wk High:48.360

52wk Low:3.605

Shares:457.00M

HK Float Shares:420.29M

Volume Ratio:0.71

T/O Rate:1.28%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.921

ROE:-41.16%

ROA:-20.15%

PB:1.51

PE(LYR):-3.95

PS:9.29

Loading ...

Overview Company News Filings

INNOGEN-B’s May 2026 Monthly Return Shows Stable Share Structure and Compliance With Public Float Rules

Bulletin Express

INNOGEN-B Shares Surge Over 6% Ahead of Key Clinical Data Presentation at ADA 2026

Movement Alert｜Yinnuo Pharma-B Rises 10.68% in Regular Trading, Share Award Plan and Commercialization Acceleration Drive Gains

INNOGEN-B Proposes Adoption of Share Incentive Scheme

Guangzhou Innogen proposes 10-year share award scheme with 10% issuance cap

Guangzhou Innogen Pharmaceutical proposes re-election of entire board slate for three-year term

Innogen says Phase IIb trial shows efsubaglutide alfa cuts weight up to 10.58% in adults with obesity

Stock Track | INNOGEN-B Plummets 6.52% Intraday as Cornerstone Investor Lock-ups Expire

Hong Kong Stocks Midday Recap: Hang Seng Index Dips 0.87%, Robotics Sector Surges Against Market Trend

Stock Track | INNOGEN-B Plummets 5.46% Intraday as Lock-Up Period Expires and Financial Losses Widen

INNOGEN-B Shares Extend Losses as Lock-Up Period Nears End

INNOGEN-B Shares Plunge Over 9% Following Previous Day's Surge, Lock-Up Period for Cornerstone Investors Nears End

INNOGEN-B Shares Surge Over 43% in Morning Trading; Phase III Weight Loss Data for Suba Anticipated by End-2026

INNOGEN-B Shares Hit Record Low as Lock-Up Expiry Nears

Innogen Pharmaceutical Reports No Share Capital Changes in April 2026; Public Float Remains Compliant

Bulletin Express

英诺加医药2025年首度实现收入破1.31509亿元，推进糖尿病及代谢病产品全球布局

Bulletin Express

Guangzhou Innogen Pharma publishes 2025 annual report

Domestic Long-Acting GLP-1 Drug Tops 100 Million Yuan in First-Year Sales but Faces Deepening Losses

INNOGEN-B (02591): 2025 Losses Nearly Double Amid Strategic Transition, Share Price Plummets Over 70%

INNOGEN-B Shares Climb Over 3% in Morning Session as Esupaglutide Alpha Added to Qilu Insurance List

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/02591/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"INNOGEN-B","latestPrice":3.635,"timestamp":1788163728003,"preClose":3.795,"halted":0,"volume":5391344,"delay":0,"changeRate":-0.04216073781291176,"floatShares":420285370,"shares":457000000,"eps":-0.921353963364451,"marketStatus":"Closed","change":-0.16,"latestTime":"08-31 16:08:48","open":3.8,"high":3.8,"low":3.605,"amount":19668366,"amplitude":0.051383,"askPrice":3.64,"askSize":2600,"bidPrice":3.635,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":-0.8591975589625417,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":5,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":3.795,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.708645,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-20.15%","roe":"-41.16%","lyrEps":-0.921354,"volumeRatio":0.708645,"shares":457000000,"dividePrice":0,"high":3.8,"amplitude":0.051383,"preClose":3.795,"low":3.605,"week52Low":3.605,"pbRate":"1.51","psRate":"9.29","week52High":48.36,"institutionHeld":0,"latestPrice":3.635,"committee":0.395349,"eps":-0.921353963364451,"divideRate":0,"volume":5391344,"delay":0,"ttmEps":-0.8591975589625417,"open":3.8,"prevYearClose":30.64,"prevWeekClose":3.795,"prevMonthClose":7.26,"prevQuarterClose":7.09,"fiveDayClose":4.065,"twentyDayClose":7.09,"sixtyDayClose":9.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02591","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775923200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-08-28","current":-4.230692,"percent":1,"low":-137.156472,"twenty":-68.330506,"median":-49.617462,"eighty":-11.852702,"high":-4.445704,"avg":-44.9056,"sd":30.195085,"marketCap":1733629429},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327},{"date":"2026-02-13","current":-50.165477,"twenty":-79.691019,"median":-62.941647,"eighty":-57.039695,"marketCap":12608214032},{"date":"2026-02-20","current":-50.419859,"twenty":-79.623791,"median":-62.643943,"eighty":-56.891323,"marketCap":12653895967},{"date":"2026-02-27","current":-50.052949,"twenty":-79.470699,"median":-62.017016,"eighty":-56.651056,"marketCap":12699577902},{"date":"2026-03-06","current":-43.88908,"twenty":-79.397543,"median":-60.902753,"eighty":-56.29247,"marketCap":11045891858},{"date":"2026-03-13","current":-39.965904,"twenty":-79.214462,"median":-60.292057,"eighty":-54.71959,"marketCap":10104843999},{"date":"2026-03-20","current":-39.174717,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"marketCap":9867297938},{"date":"2026-03-27","current":-24.701097,"twenty":-78.775514,"median":-59.491697,"eighty":-50.290678,"marketCap":9547524394},{"date":"2026-04-02","current":-24.535908,"twenty":-78.383597,"median":-58.823921,"eighty":-50.052949,"marketCap":9529251620},{"date":"2026-04-10","current":-24.978414,"twenty":-78.348547,"median":-58.584467,"eighty":-49.631191,"marketCap":9775934068},{"date":"2026-04-17","current":-23.474521,"twenty":-78.227102,"median":-58.112982,"eighty":-48.421657,"marketCap":9191205301},{"date":"2026-04-24","current":-19.658213,"twenty":-78.155492,"median":-57.844151,"eighty":-44.116877,"marketCap":7697406030},{"date":"2026-04-30","current":-16.329046,"twenty":-77.825679,"median":-57.660489,"eighty":-41.074266,"marketCap":6395470886},{"date":"2026-05-08","current":-17.822364,"twenty":-77.322024,"median":-57.626503,"eighty":-40.478309,"marketCap":5778764764},{"date":"2026-05-15","current":-17.368107,"twenty":-77.157551,"median":-57.517602,"eighty":-40.012158,"marketCap":5646287153},{"date":"2026-05-22","current":-17.112125,"twenty":-76.782452,"median":-57.446424,"eighty":-25.37304,"marketCap":5550355090},{"date":"2026-05-29","current":-15.607197,"twenty":-76.252433,"median":-57.23775,"eighty":-24.916387,"marketCap":5079831160},{"date":"2026-06-05","current":-14.014909,"twenty":-75.020932,"median":-57.073515,"eighty":-24.414835,"marketCap":4568193490},{"date":"2026-06-12","current":-11.752443,"twenty":-74.621039,"median":-56.924891,"eighty":-23.900197,"marketCap":3828146144},{"date":"2026-06-18","current":-10.549084,"twenty":-74.404407,"median":-56.73827,"eighty":-23.474521,"marketCap":3444417891},{"date":"2026-06-26","current":-9.60263,"twenty":-74.160764,"median":-56.642046,"eighty":-20.865982,"marketCap":3120076153},{"date":"2026-07-03","current":-11.351574,"twenty":-74.088566,"median":-56.533624,"eighty":-19.581214,"marketCap":3691100339},{"date":"2026-07-10","current":-11.238926,"twenty":-74.037218,"median":-56.208644,"eighty":-19.055481,"marketCap":3649986598},{"date":"2026-07-17","current":-10.540302,"twenty":-73.42668,"median":-55.144116,"eighty":-17.753872,"marketCap":3435281504},{"date":"2026-07-24","current":-10.636027,"twenty":-71.947117,"median":-53.621015,"eighty":-17.028947,"marketCap":3467258858},{"date":"2026-07-31","current":-10.1543,"twenty":-71.465685,"median":-51.153424,"eighty":-16.590446,"marketCap":3316508473},{"date":"2026-08-07","current":-10.609247,"twenty":-70.999854,"median":-50.412223,"eighty":-15.817726,"marketCap":3471827052},{"date":"2026-08-14","current":-9.215586,"twenty":-70.625283,"median":-50.222782,"eighty":-14.020929,"marketCap":3019575896},{"date":"2026-08-21","current":-5.675745,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"marketCap":1863822943},{"date":"2026-08-28","current":-4.445704,"twenty":-68.330506,"median":-49.617462,"eighty":-11.852702,"marketCap":1733629429}],"updateTime":1788176074750},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134785093","title":"INNOGEN-B’s May 2026 Monthly Return Shows Stable Share Structure and Compliance With Public Float Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=1134785093","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134785093?lang=en_us&edition=fundamental","pubTime":"2026-06-03 17:25","pubTimestamp":1780478754,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for the period ended 31 May 2026, confirming that no changes occurred in either authorised or issued share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162227797","title":"INNOGEN-B Shares Surge Over 6% Ahead of Key Clinical Data Presentation at ADA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1162227797","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162227797?lang=en_us&edition=fundamental","pubTime":"2026-06-03 11:08","pubTimestamp":1780456101,"startTime":"0","endTime":"0","summary":"Shares of INNOGEN-B (02591) have risen more than 6%. At the time of writing, the stock is up 5.79% to HK$10.62, with a turnover of HK$90.33 million.The company has announced that it will present data...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","02591","BK1161","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116975222","title":"Movement Alert｜Yinnuo Pharma-B Rises 10.68% in Regular Trading, Share Award Plan and Commercialization Acceleration Drive Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1116975222","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116975222?lang=en_us&edition=fundamental","pubTime":"2026-06-03 10:38","pubTimestamp":1780454339,"startTime":"0","endTime":"0","summary":"On June 3, Yinnuo Pharma-B rose 10.68% in regular trading, trading at 11.37 HKD/share, with trading volume of approximately 29.62 million HKD, significantly outperforming the broader Biotechnology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132169066","title":"INNOGEN-B Proposes Adoption of Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1132169066","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132169066?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:40","pubTimestamp":1780324820,"startTime":"0","endTime":"0","summary":"INNOGEN-B (HKEX: 02591) has announced that its board of directors has proposed the adoption of a share reward plan.In accordance with the provisions of the company's articles of association, a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161","BK0251","301122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640505849","title":"Guangzhou Innogen proposes 10-year share award scheme with 10% issuance cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2640505849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640505849?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:24","pubTimestamp":1780323892,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group proposed a 10-year Share Award Scheme, set to take effect on June 29, 2026, subject to shareholder approval.Scheme mandate caps awards at 10% of issued shares, excluding treasury shares; service provider awards capped at 1% as a sublimit.Based on 456,819,349 shares outstanding, the mandate limit equals 45,681,934 shares; the service provider sublimit equals 4,568,193 shares.Award shares may be satisfied via new H shares issued to a trustee, H shares bought in the market, or transfers of treasury shares.Vesting set by the board per grant; standard minimum vesting is 12 months, with limited exceptions for employee participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLDJ9T3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640528579","title":"Guangzhou Innogen Pharmaceutical proposes re-election of entire board slate for three-year term","url":"https://stock-news.laohu8.com/highlight/detail?id=2640528579","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640528579?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:16","pubTimestamp":1780319760,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group set a shareholder vote to re-elect its entire board for a new three-year term.Proposed executive directors include founder-chairman and general manager Wang Qinghua, a metabolic-disease researcher with academic posts at the University of Toronto.Finance chief and board secretary Jiang Fan, a former strategy consultant and pharma investment-and-financing executive, is also up for re-election as an executive director.The board also proposed abolishing the supervisory committee, shifting oversight to a revised governance structure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLWqCX4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639620422","title":"Innogen says Phase IIb trial shows efsubaglutide alfa cuts weight up to 10.58% in adults with obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2639620422","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639620422?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:09","pubTimestamp":1780060155,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group flagged Phase IIb ENLIGHT results for obesity drug efsubaglutide alfa for presentation at the ADA meeting on June 8, 2026.The trial met its primary endpoint, with treated participants showing meaningful weight loss versus placebo and continued reduction through the dosing period.Innogen also reported improvements in body composition and metabolic markers, with weight loss driven mainly by fat rather than muscle.Safety looked manageable, with no hypoglycemia reported and mostly mild-to-moderate gastrointestinal side effects.The data set underpins plans to advance efsubaglutide alfa into Phase III development in obesity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL5SQw8z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160792896","title":"Stock Track | INNOGEN-B Plummets 6.52% Intraday as Cornerstone Investor Lock-ups Expire","url":"https://stock-news.laohu8.com/highlight/detail?id=1160792896","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160792896?lang=en_us&edition=fundamental","pubTime":"2026-05-15 12:12","pubTimestamp":1778818329,"startTime":"0","endTime":"0","summary":"INNOGEN-B's stock price plummeted 6.52% during Friday's intraday trading session, with the decline occurring around mid-morning.The sharp drop came as cornerstone investor lock-ups expired, allowing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168389053","title":"Hong Kong Stocks Midday Recap: Hang Seng Index Dips 0.87%, Robotics Sector Surges Against Market Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1168389053","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168389053?lang=en_us&edition=fundamental","pubTime":"2026-05-15 12:09","pubTimestamp":1778818154,"startTime":"0","endTime":"0","summary":"The Hang Seng Index fell 0.87%, dropping 229 points to 26,159 in morning trading, while the Hang Seng Tech Index declined 1.26%. Morning session turnover reached HKD 151.1 billion. Tesla's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600699","03317","HHImain","02715","MCHmain","003021","01801","00699","HSI","02432","02591","03986","BK4585","002747","01208","603986","HTImain","HSImain","02833","06127","00358","603127","02692","HSTECH","513600","00241","BK1116","01888","600362","BK1183","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147698784","title":"Stock Track | INNOGEN-B Plummets 5.46% Intraday as Lock-Up Period Expires and Financial Losses Widen","url":"https://stock-news.laohu8.com/highlight/detail?id=1147698784","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147698784?lang=en_us&edition=fundamental","pubTime":"2026-05-14 14:19","pubTimestamp":1778739592,"startTime":"0","endTime":"0","summary":"INNOGEN-B's stock price plummeted 5.46% during intraday trading on Thursday, continuing a downward trend following a significant surge earlier in the week.The decline comes ahead of the expiration of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122129496","title":"INNOGEN-B Shares Extend Losses as Lock-Up Period Nears End","url":"https://stock-news.laohu8.com/highlight/detail?id=1122129496","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122129496?lang=en_us&edition=fundamental","pubTime":"2026-05-14 14:18","pubTimestamp":1778739501,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) saw its share price decline by over 5%, continuing a downward trend after a significant surge earlier in the week. The stock had jumped more than 32% on heavy volume this past...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","02591","BK1161","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198355694","title":"INNOGEN-B Shares Plunge Over 9% Following Previous Day's Surge, Lock-Up Period for Cornerstone Investors Nears End","url":"https://stock-news.laohu8.com/highlight/detail?id=1198355694","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198355694?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:01","pubTimestamp":1778572884,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) fell more than 9% today, after closing up over 32% in the previous trading session. As of the time of writing, the stock was down 9.1% to HK$15.18, with a turnover of HK$131...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","02591","VXUS","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160489079","title":"INNOGEN-B Shares Surge Over 43% in Morning Trading; Phase III Weight Loss Data for Suba Anticipated by End-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1160489079","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160489079?lang=en_us&edition=fundamental","pubTime":"2026-05-11 11:42","pubTimestamp":1778470951,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) rose over 43% in morning trading. As of the time of writing, the stock was up 42.21%, trading at HK$17.99 with a turnover of HK$173 million. According to the company's annual...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","VXUS","02591","BK4588","BK4134","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129972784","title":"INNOGEN-B Shares Hit Record Low as Lock-Up Expiry Nears","url":"https://stock-news.laohu8.com/highlight/detail?id=1129972784","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129972784?lang=en_us&edition=fundamental","pubTime":"2026-05-07 14:18","pubTimestamp":1778134696,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) fell more than 7% in afternoon trading, hitting a record low of HK$12.33. At the time of writing, the stock was down 6.16% at HK$12.49, with a turnover of HK$11.02 million. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IPOS","VXUS","BK1161","BK4588","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181023653","title":"Innogen Pharmaceutical Reports No Share Capital Changes in April 2026; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1181023653","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181023653?lang=en_us&edition=fundamental","pubTime":"2026-05-06 11:23","pubTimestamp":1778037794,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (Innogen Pharmaceutical) submitted its Monthly Return for Equity Issuer covering the period ended 30 April 2026. Key points are as follows: • Stable...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178804191","title":"英诺加医药2025年首度实现收入破1.31509亿元，推进糖尿病及代谢病产品全球布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1178804191","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178804191?lang=en_us&edition=fundamental","pubTime":"2026-04-28 23:07","pubTimestamp":1777388830,"startTime":"0","endTime":"0","summary":"2025年度，英诺加医药集团有限公司（股份代号：02591，简称“INNOGEN-B”）实现自成立以来的首次营收，报告期内收入约人民币1.31509亿元，主要来自集团核心长效GLP-1受体激动剂Efsugablutide...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"英诺加医药2025年首度实现收入破1.31509亿元，推进糖尿病及代谢病产品全球布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630863075","title":"Guangzhou Innogen Pharma publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630863075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630863075?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:53","pubTimestamp":1777387985,"startTime":"0","endTime":"0","summary":"Innogen Pharma annual report for year ended Dec. 31, 2025 flagged a strategic shift toward commercial execution following launch of core GLP-1 product Diabegone  in mainland China in February 2025.Product reached a reimbursement milestone in December 2025 with inclusion in China National Reimbursement Drug List for adult type 2 diabetes, effective Jan. 1, 2026.Group recorded first year of scalable product sales with revenue of RMB 131.51 million, reflecting initial market penetration in China.Pipeline advanced in weight management with Phase III China obesity and overweight study completing enrollment in November 2025, with completion targeted in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical Grou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3jCf9s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100842642","title":"Domestic Long-Acting GLP-1 Drug Tops 100 Million Yuan in First-Year Sales but Faces Deepening Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=1100842642","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100842642?lang=en_us&edition=fundamental","pubTime":"2026-04-24 16:12","pubTimestamp":1777018368,"startTime":"0","endTime":"0","summary":"INNOGEN-B has become the first domestic company to commercialize a long-acting GLP-1 drug following the approval of its Esupaglutide α injection in 2025. One year later, the company released its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591","BK4144","BK4590","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127480276","title":"INNOGEN-B (02591): 2025 Losses Nearly Double Amid Strategic Transition, Share Price Plummets Over 70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127480276","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127480276?lang=en_us&edition=fundamental","pubTime":"2026-04-06 20:18","pubTimestamp":1775477936,"startTime":"0","endTime":"0","summary":"The year 2025 marked a pivotal period of strategic transformation for INNOGEN-B (02591), as the company shifted from a pure research and development focus to a dual approach integrating R&D with...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147586009","title":"INNOGEN-B Shares Climb Over 3% in Morning Session as Esupaglutide Alpha Added to Qilu Insurance List","url":"https://stock-news.laohu8.com/highlight/detail?id=1147586009","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147586009?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:38","pubTimestamp":1775093921,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) rose more than 3% during morning trading. At the time of writing, the stock was up 2.94% to HK$22.22, with a turnover of HK$1.966 million. On April 1, INNOGEN announced via its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VXUS","BK4585","02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":104,"code":"91000000","status":"200"}]}}